Re: Restoring invisible and abandoned trials: a call for people to publish the findings
Doshi and colleagues are concerned, understandably, at the use of control injections in vaccine trials, that are not true placebos. (1)
Perhaps there would be even more concern if people understood that such practices are not unusual, in vaccine trials.
The nature of any control injections, in vaccine trials, is sometimes difficult to ascertain, as Doshi and colleagues’ letter suggests.
In his chapter on vaccine safety, Moskowitz lists the sixteen vaccines that were mandated in the USA, in 2017. (2)
Four of the vaccines were subject to trials that used unspecified “placebos” as controls.
Five of the vaccines had no record of controlled safety studies.
Six of the vaccines were subject to trials where other vaccines were given as the control injections.
In the case of one vaccine, the control injection was a “placebo”, phenol 0.25%.
Rapid Response:
Re: Restoring invisible and abandoned trials: a call for people to publish the findings
Doshi and colleagues are concerned, understandably, at the use of control injections in vaccine trials, that are not true placebos. (1)
Perhaps there would be even more concern if people understood that such practices are not unusual, in vaccine trials.
The nature of any control injections, in vaccine trials, is sometimes difficult to ascertain, as Doshi and colleagues’ letter suggests.
In his chapter on vaccine safety, Moskowitz lists the sixteen vaccines that were mandated in the USA, in 2017. (2)
Four of the vaccines were subject to trials that used unspecified “placebos” as controls.
Five of the vaccines had no record of controlled safety studies.
Six of the vaccines were subject to trials where other vaccines were given as the control injections.
In the case of one vaccine, the control injection was a “placebo”, phenol 0.25%.
1 https://www.bmj.com/content/346/bmj.f2865/rr-7
2 Richard Moskowitz, MD, Vaccines, a reappraisal. Skyhorse Publishing, 2017. (pp34 et seq)
Competing interests: No competing interests